Evidence method
Level · gp.fundamentals.debt_to_revenue
161.79% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
PAHC · Mar 31, 2026
PHIBRO ANIMAL HEALTH CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-056280General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.99% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.23% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
10.27% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
140.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
32.77% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
11.64% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.11% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20255/8 normalizedLevel 3Sep 30, 20256/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 166.95%
- Current
- 161.79%
- Delta
- -5.16%
- Previous
- 2.97%
- Current
- 3.99%
- Delta
- 1.03%
- Previous
- 5.18%
- Current
- 4.23%
- Delta
- -0.95%
- Previous
- 20.90%
- Current
- 10.27%
- Delta
- -10.64%
- Previous
- 138.36%
- Current
- 140.71%
- Delta
- 2.35%
- Previous
- 35.48%
- Current
- 32.77%
- Delta
- -2.71%
- Previous
- 13.46%
- Current
- 11.64%
- Delta
- -1.82%
- Previous
- 0.12%
- Current
- 0.11%
- Delta
- -0.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Derived From · PAHC Company Quality Vector →Has State · PHIBRO ANIMAL HEALTH CORP →Transitioned To · PAHC Fundamental State →Transitioned To · PAHC BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PAHC CAPEX_INTENSITY_INCREASED →Transitioned To · PAHC CASH_GENERATION_DECREASED →Transitioned To · PAHC GROWTH_DECREASED →Transitioned To · PAHC INVENTORY_PRESSURE_INCREASED →Transitioned To · PAHC MARGIN_DECREASED →Transitioned To · PAHC PROFITABILITY_DECREASED →Transitioned To · PAHC SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.